Analyst Ratings for Sucampo Pharmaceuticals Inc. Cl A (SCMP)Updated: 2017-07-28
An average rating of Buy has been given to Sucampo Pharmaceuticals Inc. Cl A (NASDAQ:SCMP) by analysts covering the stock. SCMP had previously received a consensus rating of Buy a month ago.
4 analysts declared SCMP a buy, 0 issued an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Many analysts weighed in on price targets for SCMP. The most optimistic analyst gave a price target of 29.5, which equates to a potential upside of 171.89 percent. The most pessimistic price target was 11, implying potential capital losses of 1.38 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -8.07 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -12.21 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.
SCMP has an estimated earnings growth rate of 66.42 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. SCMP has a PEG ratio of 0.27.
In the trailing 52-weeks, SCMP hit 17.55 at the highest peak, while it's lowest trading point was 9.30. The current market price is above the trailing year's low by 16.67 percent, and 38.18 percent lower than its 52-week high. SCMP has a price/earnings ratio of 17.79. Investors typically compare the P/E ratio to a company's peers in the industry. The SCMP value stock report compares SCMP to some of its peers using value stock charts. The stock has a market capitalization of $0.50182 billion. SCMP is estimated to release their earnings results for the quarter on 0000-00-00, days from today.